Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

335
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
335
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

227
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
227
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

290
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
290
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

238
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
238
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

150
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
150
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

233
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
233

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates.

Angewandte Chemie (International ed. in English)·2026
Same author

Prediction of antibody non-specificity using protein language models and biophysical parameters.

mAbs·2026
Same author

De novo design of peptides localizing at the interface of biomolecular condensates.

Nature communications·2026
Same author

Competition between protein-RNA clustering and phase separation drives re-entrant phase behavior of hnRNPA1.

Nature communications·2026
Same author

Rational Design of Zwitterionic Polymers with Tunable Phase Separation Propensity.

Macromolecules·2026
Same author

Structural defects in amyloid-β fibrils drive secondary nucleation.

Nature communications·2026
Same journal

Mechanistic Insight into Self-Gelation Involved in Prescription Design for Optimization of Tablet Performance.

Molecular pharmaceutics·2026
Same journal

[<sup>68</sup>Ga]Ga-DOTA-DP-UBI 29-41: A Novel <sup>68</sup>Ga-Labeled Ubiquicidin 29-41 Derivative Containing d-Proline for Bacterial Infection PET Imaging.

Molecular pharmaceutics·2026
Same journal

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Molecular pharmaceutics·2026
Same journal

Preclinical Evaluation of <sup>177</sup>Lu-Labeled Anti-CLDN18.2 VHH-Fc for Radioimmunotherapy in Gastric Cancer.

Molecular pharmaceutics·2026
Same journal

The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films.

Molecular pharmaceutics·2026
Same journal

Call For Papers: Molecular Understanding and Formulation Design for Peptide Delivery.

Molecular pharmaceutics·2026
查看所有相关文章

相关实验视频

Updated: Jan 16, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K

贝叶斯优化为高效的多目标配方开发生物制剂的贝叶斯优化.

Isabel Waibel1, Timo N Schneider1, Fiona J Fischer1

  • 1Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zürich, Vladimir-Prelog-Weg 1-5/10, Zürich 8093, Switzerland.

Molecular pharmaceutics
|September 26, 2025
PubMed
概括
此摘要是机器生成的。

开发生物制剂需要优化配方设计. 这项研究引入了一种机器学习方法,通过优化关键的生物物理性质,减少实验需求,有效地提高抗体开发能力.

关键词:
贝叶斯优化是贝叶斯的优化.开发能力 开发能力辅助剂 辅助剂 辅助剂机器学习是机器学习.一个单克隆抗体.多目标优化优化这是一种蛋白质配方.

更多相关视频

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.8K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.6K

相关实验视频

Last Updated: Jan 16, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.8K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.6K

科学领域:

  • 生物制药配方开发发展
  • 蛋白质生物物理学 蛋白质生物物理学
  • 计算化学是一种计算化学.

背景情况:

  • 生物学家经常面临着影响治疗翻译的可开发性挑战.
  • 配方设计复杂,需要同时优化多个生物物理性质和辅助剂相互作用.
  • 传统的方法在配方设计中与高阶复杂性和局部最佳情况作斗争.

研究的目的:

  • 开发一种基于机器学习的高效方法来优化生物配方.
  • 为了同时优化单克隆抗体的多个关键生物物理性质.
  • 通过结合度和pH等配方约束来确保实际适用性.

主要方法:

  • 结合贝叶斯优化和高通量实验选.
  • 在配方特征之间建模非线性关系和相互作用.
  • 优化化温度 (Tm),扩散相互作用参数 (kD) 和空气-水接口稳定性.

主要成果:

  • 仅在33个实验中确定了高度优化的配方条件.
  • 证明了该方法能够考虑配方约束 (度,pH) 的能力.
  • 提供了对辅助剂影响的见解,并突出了冲突性质之间的权衡 (例如,pH对Tm和kD的影响).

结论:

  • 机器学习,特别是选的贝叶斯优化,显著减少了制定优化所需的实验.
  • 开发的方法有效地导航复杂的设计空间,以提高生物开发能力.
  • 该方法提供了对配方组件和物质权衡的实用见解,以获得成功的治疗转化.